Radiomic biomarkers from PET/CT multi-modality fusion images for the prediction of immunotherapy response in advanced non-small cell lung cancer patients
Author:
Publisher
SPIE
Reference24 articles.
1. Lung cancer statistics;Torre,2016
2. Immunotherapy in Non–Small Cell Lung Cancer Treatment
3. Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
4. Immune checkpoint modulation for non–small cell lung cancer;Soria,2015
5. Combining radiomics and mathematical modeling to elucidate mechanisms of resistance to immune checkpoint blockade in non-small cell lung cancer;Saeed-Vafa,2017
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and validation of survival prognostic models for head and neck cancer patients using machine learning and dosiomics and CT radiomics features: a multicentric study;Radiation Oncology;2024-01-22
2. Exploring the potential of Radiomics in identification and treatment of lung cancer: A systematic evaluation;Multimedia Tools and Applications;2023-12-29
3. Data and model aggregation for radiomics applications: Emerging trend and open challenges;Information Fusion;2023-12
4. Immunotherapy Efficacy Prediction for Non-Small Cell Lung Cancer Using Multi-View Adaptive Weighted Graph Convolutional Networks;IEEE Journal of Biomedical and Health Informatics;2023-11
5. Qualitative analysis of PD-L1 expression in non-small-cell lung cancer based on chest CT radiomics;Biomedical Signal Processing and Control;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3